Lowering the chance of type 2 diabetes after gestational diabetes
Policy levers to reduce diabetes after gestational diabetes
This project looks at how neighborhood conditions and public policies might help lower the chance of type 2 diabetes for women who had high blood sugar during pregnancy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11290843 on NIH RePORTER |
What this research studies
If you had high blood sugar during pregnancy (gestational diabetes), researchers linked New York City birth records with city HbA1c lab results to follow a large, multiethnic group of women after delivery. They will compare diabetes rates across racial and ethnic groups and examine neighborhood factors such as access to healthy food, healthcare, and housing that may affect risk in the postpartum years. The team is searching for policy "levers"—changes at the neighborhood or city level—that could reduce later diabetes and related heart disease. This work builds on the APPLE NYC cohort of births from 2009–2017 and uses population-level data rather than enrolling a new clinical trial cohort.
Who could benefit from this research
Good fit: Women who experienced gestational diabetes—particularly those who gave birth in New York City and represent Black, Hispanic, South Asian, East Asian, or White racial/ethnic groups—are the primary focus.
Not a fit: People who never had gestational diabetes, men, or women living outside the study's geographic scope are unlikely to receive direct benefit from this specific project.
Why it matters
Potential benefit: If successful, the project could identify policies that reduce postpartum diabetes and lower long-term diabetes and cardiovascular risk for women who had gestational diabetes.
How similar studies have performed: Prior studies have focused on individual risk factors after gestational diabetes, but linking birth certificates with HbA1c registries to target neighborhood and policy interventions is relatively novel.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Janevic, Teresa — Columbia University Health Sciences
- Study coordinator: Janevic, Teresa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.